Francesco Annunziato Selected Research

Francesco Annunziato Research Topics

Disease

17	Inflammation (Inflammations) 01/2024 - 07/2002
13	COVID-19 12/2023 - 01/2020
9	Infections 02/2024 - 01/2007
9	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021 - 05/2014
8	Neoplasms (Cancer) 01/2022 - 06/2003
7	Asthma (Bronchial Asthma) 12/2021 - 01/2010
4	Fibrosis (Cirrhosis) 10/2023 - 10/2003
4	Hypersensitivity (Allergy) 09/2023 - 04/2011
3	Disease Progression 01/2023 - 09/2020
3	Arthritis (Polyarthritis) 01/2021 - 01/2016
2	Polyploidy 10/2023 - 10/2022
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023 - 11/2015
2	Acute Kidney Injury (Acute Renal Failure) 10/2022 - 12/2007
2	Glomerulonephritis 10/2022 - 01/2002
2	Atopic Dermatitis (Atopic Eczema) 09/2021 - 09/2017
2	Pain (Aches) 01/2018 - 01/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016 - 02/2007
2	Fistula 01/2015 - 01/2013
2	Crohn Disease (Crohn's Disease) 01/2013 - 08/2007
2	Myocardial Infarction 10/2010 - 08/2005
1	Pulmonary Alveolar Proteinosis 02/2024
1	Nocardia Infections 02/2024
1	Food Hypersensitivity (Food Allergy) 09/2023
1	Neuroblastoma 05/2023
1	Colitis 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Post-Acute COVID-19 Syndrome 10/2022
1	Chronic Renal Insufficiency 10/2022
1	Opportunistic Infections (Opportunistic Infection) 01/2022
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022
1	Biliary Tract Diseases 01/2022
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2022
1	Myocarditis (Carditis) 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Type 1 Hyper-IgM Immunodeficiency Syndrome 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022
1	Leishmaniasis 01/2022

Drug/Important Bio-Agent (IBA)

12	CytokinesIBA 01/2022 - 02/2003
6	Messenger RNA (mRNA)IBA 01/2023 - 01/2002
6	VaccinesIBA 12/2022 - 10/2007
5	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2008
5	Proteins (Proteins, Gene)FDA Link 09/2023 - 01/2002
4	AllergensIBA 09/2023 - 02/2003
4	Monoclonal AntibodiesIBA 11/2022 - 12/2020
4	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2010
4	AntigensIBA 01/2021 - 01/2007
4	ChemokinesIBA 01/2008 - 01/2002
3	tocilizumab (atlizumab)FDA Link 12/2023 - 12/2020
3	Immunoglobulin E (IgE)IBA 09/2023 - 12/2018
3	Oxygen (Dioxygen)IBA 10/2022 - 12/2020
3	Immunoglobulin M (IgM)IBA 01/2022 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2009
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 12/2019
3	ruxolitinibIBA 11/2021 - 11/2017
2	AutoantibodiesIBA 02/2024 - 12/2019
2	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 10/2022
2	Omalizumab (Xolair)FDA Link 11/2022 - 12/2018
2	C-Reactive ProteinIBA 01/2022 - 09/2020
2	EnzymesIBA 05/2021 - 01/2016
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 09/2020 - 01/2020
2	SteroidsIBA 01/2018 - 02/2016
2	Interferon-gamma (Interferon, gamma)IBA 12/2009 - 01/2002
1	AntibodiesIBA 02/2024
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2024
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2023
1	lipid transfer protein (glycolipid transfer protein)IBA 09/2023
1	GibberellinsIBA 09/2023
1	CholesterolIBA 05/2023
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	Bendamustine Hydrochloride FDA Link 01/2023
1	Dextrans (Dextran)FDA Link 01/2023
1	anti-IgE antibodiesIBA 11/2022
1	dupilumabIBA 11/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2022
1	remdesivirIBA 10/2022
1	PanobinostatIBA 10/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022
1	erucylphosphocholineIBA 01/2022
1	CD40 Ligand (CD40L)IBA 01/2022
1	mepolizumabIBA 01/2022
1	TransferasesIBA 01/2022
1	Carnitine palmitoyl transferase 2 deficiencyIBA 01/2022
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022
1	ProcalcitoninIBA 01/2022
1	Thymic Stromal LymphopoietinIBA 12/2021
1	tezepelumabIBA 12/2021
1	AlarminsIBA 12/2021
1	EmollientsIBA 09/2021

Therapy/Procedure

10	Therapeutics 01/2023 - 12/2007
3	Critical Care (Surgical Intensive Care) 01/2021 - 01/2020
2	Biological Therapy 11/2022 - 12/2016
2	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2010 - 08/2005
1	Precision Medicine 01/2024
1	Drug Therapy (Chemotherapy) 01/2023
1	Aftercare (After-Treatment) 01/2023